$FUSN Fusion filed for a $100M #IPO

- Next-gen radiopharmaceuticals: "Targeted Alpha Therapies"
- Lead (FPI-1434) targets IGF-1R w/ actinium-225
- Investors include OrbiMed, Varian, Perceptive, Pivotal, Rock Springs, $JNJ, Healthcap, TPG, CPPIB, etc

S-1: https://t.co/TnTKlSx5LJ https://t.co/ECvUGqz9kg